Published in J Clin Invest on May 15, 2012
Methylglyoxal, the dark side of glycolysis. Front Neurosci (2015) 1.16
The diverse ligand repertoire of the receptor for advanced glycation endproducts and pathways to the complications of diabetes. Vascul Pharmacol (2012) 1.12
Traumatic stress, oxidative stress and post-traumatic stress disorder: neurodegeneration and the accelerated-aging hypothesis. Mol Psychiatry (2014) 1.12
Measurement of methylglyoxal by stable isotopic dilution analysis LC-MS/MS with corroborative prediction in physiological samples. Nat Protoc (2014) 1.10
Role of Glyoxalase 1 (Glo1) and methylglyoxal (MG) in behavior: recent advances and mechanistic insights. Front Genet (2012) 0.95
Glyoxalase 1 and its substrate methylglyoxal are novel regulators of seizure susceptibility. Epilepsia (2013) 0.87
Dicarbonyls and glyoxalase in disease mechanisms and clinical therapeutics. Glycoconj J (2016) 0.84
Glo1 inhibitors for neuropsychiatric and anti-epileptic drug development. Biochem Soc Trans (2014) 0.83
Lactoylglutathione lyase, a critical enzyme in methylglyoxal detoxification, contributes to survival of Salmonella in the nutrient rich environment. Virulence (2015) 0.82
Oxidative imbalance and anxiety disorders. Curr Neuropharmacol (2014) 0.82
Glycation and insulin resistance: novel mechanisms and unique targets? Arterioscler Thromb Vasc Biol (2012) 0.82
Methylglyoxal induces platelet hyperaggregation and reduces thrombus stability by activating PKC and inhibiting PI3K/Akt pathway. PLoS One (2013) 0.81
A large QTL for fear and anxiety mapped using an F2 cross can be dissected into multiple smaller QTLs. Genes Brain Behav (2013) 0.81
Weak association of glyoxalase 1 (GLO1) variants with autism spectrum disorder. Eur Child Adolesc Psychiatry (2014) 0.79
Anxiety genetics - findings from cross-species genome-wide approaches. Biol Mood Anxiety Disord (2013) 0.77
Increased glyoxalase-1 levels in Fkbp5 knockout mice caused by glyoxalase-1 gene duplication. G3 (Bethesda) (2013) 0.76
Association of oxidative stress to the genesis of anxiety: implications for possible therapeutic interventions. Curr Neuropharmacol (2014) 0.76
Reactive carbonyl species and their roles in sarcoplasmic reticulum Ca2+ cycling defect in the diabetic heart. Heart Fail Rev (2014) 0.75
Connecting Anxiety and Genomic Copy Number Variation: A Genome-Wide Analysis in CD-1 Mice. PLoS One (2015) 0.75
Genetic and pharmacological manipulation of glyoxalase 1 regulates voluntary ethanol consumption in mice. Addict Biol (2015) 0.75
Neuronal overexpression of Glo1 or amygdalar microinjection of methylglyoxal is sufficient to regulate anxiety-like behavior in mice. Behav Brain Res (2015) 0.75
Characteristic Variations and Similarities in Biochemical, Molecular, and Functional Properties of Glyoxalases across Prokaryotes and Eukaryotes. Int J Mol Sci (2017) 0.75
Identification of a novel, fast-acting GABAergic antidepressant. Mol Psychiatry (2017) 0.75
Statistical significance for genomewide studies. Proc Natl Acad Sci U S A (2003) 88.64
Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc (2008) 62.52
Biochemistry and molecular cell biology of diabetic complications. Nature (2001) 25.43
Emotion circuits in the brain. Annu Rev Neurosci (2000) 24.39
Variations on an inhibitory theme: phasic and tonic activation of GABA(A) receptors. Nat Rev Neurosci (2005) 9.25
Recombineering: a powerful new tool for mouse functional genomics. Nat Rev Genet (2001) 8.35
A genetic risk factor for periodic limb movements in sleep. N Engl J Med (2007) 5.77
Subunit composition, distribution and function of GABA(A) receptor subtypes. Curr Top Med Chem (2002) 4.45
Structure and pharmacology of gamma-aminobutyric acidA receptor subtypes. Pharmacol Rev (1995) 3.94
Development and validation of MIX: comprehensive free software for meta-analysis of causal research data. BMC Med Res Methodol (2006) 3.67
The mouse light/dark box test. Eur J Pharmacol (2003) 3.47
Decreased GABAA-receptor clustering results in enhanced anxiety and a bias for threat cues. Nat Neurosci (1999) 3.36
BAC to the future: the use of bac transgenic mice for neuroscience research. Nat Rev Neurosci (2001) 3.32
Measuring normal and pathological anxiety-like behaviour in mice: a review. Behav Brain Res (2001) 2.98
Glyoxalase I--structure, function and a critical role in the enzymatic defence against glycation. Biochem Soc Trans (2003) 2.69
The role of GABA(A) receptors in the acute and chronic effects of ethanol: a decade of progress. Psychopharmacology (Berl) (2009) 2.50
Extrasynaptic GABA(A) receptors: their function in the CNS and implications for disease. Neuron (2012) 2.40
Analysis of GABAA receptor function and dissection of the pharmacology of benzodiazepines and general anesthetics through mouse genetics. Annu Rev Pharmacol Toxicol (2004) 2.38
Use of the elevated plus maze in the search for novel anxiolytic agents. Trends Pharmacol Sci (1995) 2.35
Glyoxalase 1 and glutathione reductase 1 regulate anxiety in mice. Nature (2005) 2.29
The glyoxalase system in health and disease. Mol Aspects Med (1993) 2.00
Studies on the inhibition of glyoxalase I by S-substituted glutathiones. J Med Chem (1971) 1.97
Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis. J Clin Invest (1998) 1.90
Glyoxalase-1 prevents mitochondrial protein modification and enhances lifespan in Caenorhabditis elegans. Aging Cell (2008) 1.81
Role of GABA in anxiety and depression. Depress Anxiety (2007) 1.79
GABAergic mechanisms in epilepsy. Epilepsia (2001) 1.78
Presynaptic, extrasynaptic and axonal GABAA receptors in the CNS: where and why? Prog Biophys Mol Biol (2005) 1.74
Relevance of BAC transgene copy number in mice: transgene copy number variation across multiple transgenic lines and correlations with transgene integrity and expression. Mamm Genome (2007) 1.71
Restless legs syndrome: pathophysiology, clinical presentation and management. Nat Rev Neurol (2010) 1.70
Tonically activated GABAA receptors in hippocampal neurons are high-affinity, low-conductance sensors for extracellular GABA. Mol Pharmacol (2003) 1.65
Advanced glycation endproducts: what is their relevance to diabetic complications? Diabetes Obes Metab (2007) 1.64
Animal models of anxiety in mice. Fundam Clin Pharmacol (2007) 1.62
A common and unstable copy number variant is associated with differences in Glo1 expression and anxiety-like behavior. PLoS One (2009) 1.44
The dynamic modulation of GABA(A) receptor trafficking and its role in regulating the plasticity of inhibitory synapses. Physiol Rev (2011) 1.42
Identification of glyoxalase-I as a protein marker in a mouse model of extremes in trait anxiety. J Neurosci (2005) 1.40
Behavioral analyses of GHB: receptor mechanisms. Pharmacol Ther (2008) 1.31
The tandem of free radicals and methylglyoxal. Chem Biol Interact (2007) 1.31
Proteomic studies identified a single nucleotide polymorphism in glyoxalase I as autism susceptibility factor. Am J Med Genet A (2004) 1.19
Alterations in the expression of GABAA receptor subunits in cerebellar granule cells after the disruption of the alpha6 subunit gene. Eur J Neurosci (1999) 1.16
Protecting the genome: defence against nucleotide glycation and emerging role of glyoxalase I overexpression in multidrug resistance in cancer chemotherapy. Biochem Soc Trans (2003) 1.15
Amyloid beta peptide as a physiological modulator of neuronal 'A'-type K+ current. Neurobiol Aging (2005) 1.13
Methylglyoxal, protein binding and biological samples: are we getting the true measure? J Chromatogr B Analyt Technol Biomed Life Sci (2009) 1.09
Replication of restless legs syndrome loci in three European populations. J Med Genet (2009) 1.08
Role of GABAA receptors in the physiology and pharmacology of sleep. Eur J Neurosci (2009) 1.05
Pitfalls in the interpretation of genetic and pharmacological effects on anxiety-like behaviour in rodents. Behav Pharmacol (2008) 1.03
Reactive metabolites and AGE/RAGE-mediated cellular dysfunction affect the aging process: a mini-review. Gerontology (2010) 1.02
Methylglyoxal causes strong weakening of detoxifying capacity and apoptotic cell death in rat hippocampal neurons. Int J Biochem Cell Biol (2007) 1.01
Molecular targets in the treatment of anxiety. Biol Psychiatry (2002) 0.99
Enhanced carbonyl stress in a subpopulation of schizophrenia. Arch Gen Psychiatry (2010) 0.99
Treatment-resistant anxiety disorders. Mol Psychiatry (2006) 0.98
Methylglyoxal induces oxidative stress-dependent cell injury and up-regulation of interleukin-1beta and nerve growth factor in cultured hippocampal neuronal cells. Brain Res (2004) 0.96
Methylglyoxal-mediated anxiolysis involves increased protein modification and elevated expression of glyoxalase 1 in the brain. J Neurochem (2010) 0.96
Unease on the role of glyoxalase 1 in high-anxiety-related behaviour. Trends Mol Med (2006) 0.95
Neuroanatomy of anxiety. Curr Top Behav Neurosci (2010) 0.95
Reduced expression of glyoxalase-1 mRNA in mood disorder patients. Neurosci Lett (2008) 0.93
Association analysis of the functional Ala111Glu polymorphism of the glyoxalase I gene in panic disorder. Neurosci Lett (2005) 0.91
Evaluating genetic markers and neurobiochemical analytes for fluoxetine response using a panel of mouse inbred strains. Psychopharmacology (Berl) (2011) 0.90
Anxiety in mice and men: a comparison. J Neural Transm (Vienna) (2009) 0.90
Pathological effects of glyoxalase I inhibition in SH-SY5Y neuroblastoma cells. J Neurosci Res (2006) 0.90
GABA vesicles at synapses: are there 2 distinct pools? Neuroscientist (2009) 0.86
Glyoxalase I polymorphism rs2736654 causing the Ala111Glu substitution modulates enzyme activity--implications for autism. Autism Res (2011) 0.83
Antitumor activity of S-(p-bromobenzyl)glutathione diesters in vitro: a structure-activity study. J Med Chem (1996) 0.83
A simplified method for the purification of human red blood cell glyoxalase. I. Characteristics, immunoblotting, and inhibitor studies. J Protein Chem (1993) 0.78
Proteomics analysis of methylglyoxal-induced neurotoxic effects in SH-SY5Y cells. Cell Biochem Funct (2010) 0.77
In vivo enhancer analysis of human conserved non-coding sequences. Nature (2006) 10.60
The Collaborative Cross, a community resource for the genetic analysis of complex traits. Nat Genet (2004) 9.37
ECR Browser: a tool for visualizing and accessing data from comparisons of multiple vertebrate genomes. Nucleic Acids Res (2004) 4.53
Molecular structure of β-amyloid fibrils in Alzheimer's disease brain tissue. Cell (2013) 4.02
The nature and identification of quantitative trait loci: a community's view. Nat Rev Genet (2003) 3.96
Comparative genomics at the vertebrate extremes. Nat Rev Genet (2004) 3.50
High-resolution genetic mapping using the Mouse Diversity outbred population. Genetics (2012) 3.28
Evolution and functional classification of vertebrate gene deserts. Genome Res (2004) 2.92
A fine-scale chimpanzee genetic map from population sequencing. Science (2012) 2.83
Supramolecular structure in full-length Alzheimer's beta-amyloid fibrils: evidence for a parallel beta-sheet organization from solid-state nuclear magnetic resonance. Biophys J (2002) 2.78
Predicting tissue-specific enhancers in the human genome. Genome Res (2007) 2.72
Gene expression profiling leads to identification of GLI1-binding elements in target genes and a role for multiple downstream pathways in GLI1-induced cell transformation. J Biol Chem (2001) 2.56
A genomewide screen of 345 families for autism-susceptibility loci. Am J Hum Genet (2003) 2.51
An 8q24 gene desert variant associated with prostate cancer risk confers differential in vivo activity to a MYC enhancer. Genome Res (2010) 2.24
Alternative translation initiation in rat brain yields K2P2.1 potassium channels permeable to sodium. Neuron (2008) 2.21
Increasing tumor antigen expression overcomes "ignorance" to solid tumors via crosspresentation by bone marrow-derived stromal cells. Immunity (2002) 2.18
Relapse or eradication of cancer is predicted by peptide-major histocompatibility complex affinity. Cancer Cell (2013) 2.18
Seeded growth of beta-amyloid fibrils from Alzheimer's brain-derived fibrils produces a distinct fibril structure. Proc Natl Acad Sci U S A (2009) 2.15
Homotypic clusters of transcription factor binding sites are a key component of human promoters and enhancers. Genome Res (2010) 2.12
A molecular pathway including Id2, Tbx5, and Nkx2-5 required for cardiac conduction system development. Cell (2007) 2.12
Sumoylation silences the plasma membrane leak K+ channel K2P1. Cell (2005) 2.07
Genome-wide association studies and the problem of relatedness among advanced intercross lines and other highly recombinant populations. Genetics (2010) 2.06
The 2.5 Å structure of CD1c in complex with a mycobacterial lipid reveals an open groove ideally suited for diverse antigen presentation. Immunity (2010) 2.02
Genome-wide discovery of human heart enhancers. Genome Res (2010) 1.85
Abeta40-Lactam(D23/K28) models a conformation highly favorable for nucleation of amyloid. Biochemistry (2005) 1.78
Genetic analysis in the Collaborative Cross breeding population. Genome Res (2011) 1.74
Latent TGF-beta-binding protein 4 modifies muscular dystrophy in mice. J Clin Invest (2009) 1.67
Behavioral differences among C57BL/6 substrains: implications for transgenic and knockout studies. J Neurogenet (2008) 1.66
Flanking polyproline sequences inhibit beta-sheet structure in polyglutamine segments by inducing PPII-like helix structure. J Mol Biol (2007) 1.59
Transcriptional enhancers in development and disease. Genome Biol (2012) 1.52
Alterations in TCF7L2 expression define its role as a key regulator of glucose metabolism. Genome Res (2011) 1.50
In vivo characterization of a vertebrate ultraconserved enhancer. Genomics (2005) 1.49
Social neuroscience and its potential contribution to psychiatry. World Psychiatry (2014) 1.48
Enhancers: five essential questions. Nat Rev Genet (2013) 1.46
Tbx20 regulates a genetic program essential to adult mouse cardiomyocyte function. J Clin Invest (2011) 1.46
QTLRel: an R package for genome-wide association studies in which relatedness is a concern. BMC Genet (2011) 1.46
Evidence for novel beta-sheet structures in Iowa mutant beta-amyloid fibrils. Biochemistry (2009) 1.45
Peptide-based inhibitors of amyloid assembly. Methods Enzymol (2006) 1.44
A mutant chaperone converts a wild-type protein into a tumor-specific antigen. Science (2006) 1.44
A common and unstable copy number variant is associated with differences in Glo1 expression and anxiety-like behavior. PLoS One (2009) 1.44
Increasing the amphiphilicity of an amyloidogenic peptide changes the beta-sheet structure in the fibrils from antiparallel to parallel. Biophys J (2004) 1.41
Structure of substrate-free human insulin-degrading enzyme (IDE) and biophysical analysis of ATP-induced conformational switch of IDE. J Biol Chem (2007) 1.41
Regulatory variation in a TBX5 enhancer leads to isolated congenital heart disease. Hum Mol Genet (2012) 1.34
Nucleotide excision repair eliminates unique DNA-protein cross-links from mammalian cells. J Biol Chem (2007) 1.31
Association between the casein kinase 1 epsilon gene region and subjective response to D-amphetamine. Neuropsychopharmacology (2006) 1.30
Genetics of caffeine consumption and responses to caffeine. Psychopharmacology (Berl) (2010) 1.27
Genetic variation and population substructure in outbred CD-1 mice: implications for genome-wide association studies. PLoS One (2009) 1.27
Exploiting human--fish genome comparisons for deciphering gene regulation. Hum Mol Genet (2004) 1.25
Significance thresholds for quantitative trait locus mapping under selective genotyping. Genetics (2007) 1.22
Evaluation of genetic variability in the dopamine receptor D2 in relation to behavioral inhibition and impulsivity/sensation seeking: an exploratory study with d-amphetamine in healthy participants. Exp Clin Psychopharmacol (2009) 1.21
A common genetic variant within SCN10A modulates cardiac SCN5A expression. J Clin Invest (2014) 1.17
A structural model of the constitutive androstane receptor defines novel interactions that mediate ligand-independent activity. Mol Cell Biol (2002) 1.17
Genome-wide association study of d-amphetamine response in healthy volunteers identifies putative associations, including cadherin 13 (CDH13). PLoS One (2012) 1.14
Human breast cancer metastases to the brain display GABAergic properties in the neural niche. Proc Natl Acad Sci U S A (2014) 1.13
Variation in the form of Pavlovian conditioned approach behavior among outbred male Sprague-Dawley rats from different vendors and colonies: sign-tracking vs. goal-tracking. PLoS One (2013) 1.12
Hardy-Weinberg disequilibrium identified genotyping error of the serotonin transporter (SLC6A4) promoter polymorphism. Psychiatr Genet (2006) 1.12
Stability, miscoding potential, and repair of 2'-deoxyxanthosine in DNA: implications for nitric oxide-induced mutagenesis. Biochemistry (2003) 1.11
Rapid whisker movements in sleeping newborn rats. Curr Biol (2012) 1.11
Catechol-O-methyltransferase val158met genotype modulates sustained attention in both the drug-free state and in response to amphetamine. Psychiatr Genet (2010) 1.11
FTO-mediated formation of N6-hydroxymethyladenosine and N6-formyladenosine in mammalian RNA. Nat Commun (2013) 1.10
A role for casein kinase 1 epsilon in the locomotor stimulant response to methamphetamine. Psychopharmacology (Berl) (2008) 1.10
Appendage expression driven by the Hoxd Global Control Region is an ancient gnathostome feature. Proc Natl Acad Sci U S A (2011) 1.09
Candidate gene studies of a promising intermediate phenotype: failure to replicate. Neuropsychopharmacology (2012) 1.08
Dual transcriptional activator and repressor roles of TBX20 regulate adult cardiac structure and function. Hum Mol Genet (2012) 1.08
Genome-wide identification of conserved regulatory function in diverged sequences. Genome Res (2011) 1.07
Annexin A6 modifies muscular dystrophy by mediating sarcolemmal repair. Proc Natl Acad Sci U S A (2014) 1.07
TBX5 drives Scn5a expression to regulate cardiac conduction system function. J Clin Invest (2012) 1.06
Fine-mapping alleles for body weight in LG/J × SM/J F₂ and F(34) advanced intercross lines. Mamm Genome (2011) 1.05
The Japanese mutant Aβ (ΔE22-Aβ(1-39)) forms fibrils instantaneously, with low-thioflavin T fluorescence: seeding of wild-type Aβ(1-40) into atypical fibrils by ΔE22-Aβ(1-39). Biochemistry (2011) 1.05
Distinct genetic regions modify specific muscle groups in muscular dystrophy. Physiol Genomics (2010) 1.05
Advanced glycation end products of DNA: quantification of N2-(1-Carboxyethyl)-2'-deoxyguanosine in biological samples by liquid chromatography electrospray ionization tandem mass spectrometry. Chem Res Toxicol (2008) 1.00
Probing the role of backbone hydrogen bonding in beta-amyloid fibrils with inhibitor peptides containing ester bonds at alternate positions. Biochemistry (2003) 1.00
Diethylcarbamazine activity against Brugia malayi microfilariae is dependent on inducible nitric-oxide synthase and the cyclooxygenase pathway. Filaria J (2005) 0.99
A simulation study of permutation, bootstrap, and gene dropping for assessing statistical significance in the case of unequal relatedness. Genetics (2012) 0.98
Genome-wide maps of transcription regulatory elements. Wiley Interdiscip Rev Syst Biol Med (2010) 0.98
Rapid selection response for contextual fear conditioning in a cross between C57BL/6J and A/J: behavioral, QTL and gene expression analysis. Behav Genet (2008) 0.97
Genetic architecture of fear conditioning in chromosome substitution strains: relationship to measures of innate (unlearned) anxiety-like behavior. Mamm Genome (2007) 0.97
Csnk1e is a genetic regulator of sensitivity to psychostimulants and opioids. Neuropsychopharmacology (2011) 0.96
Differential cytostatic and cytotoxic action of Metallocorroles against human cancer cells: potential platforms for anticancer drug development. Chem Res Toxicol (2012) 0.96
Differences in aggressive behavior and DNA copy number variants between BALB/cJ and BALB/cByJ substrains. Behav Genet (2009) 0.96
Mechanism of cis-inhibition of polyQ fibrillation by polyP: PPII oligomers and the hydrophobic effect. Biophys J (2009) 0.95
Role of Glyoxalase 1 (Glo1) and methylglyoxal (MG) in behavior: recent advances and mechanistic insights. Front Genet (2012) 0.95